AUA Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

AUA Capital Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-550	Closed	-$24K	–	213
2017 Q4	$24K	Hold	550	–	–	0.02%	143
2017 Q3	$23K	Hold	550	–	–	0.02%	143
2017 Q2	$24K	Sell	550 -450	-45%	-$19K	0.02%	142
2017 Q1	$42K	Hold	1,000	–	–	0.04%	112
2016 Q4	$39K	Buy	+1,000	New	+$40.7K	0.04%	124

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Arnhold LLC New York $1.43B AUM 59.3% 1-Year Est. Return

AUA Capital Management's XPH Position: Q1 2018 in Review

AUA Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2018, closing a stake of 550 shares — an estimated $24K sold.

AUA Capital Management first reported a position in XPH in Q4 2016 and held it in 5 quarters. The position peaked at $42K in Q1 2017. 75 funds tracked by Wall St. Rank hold XPH as of Q1 2018.

AUA Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
AUA Capital Management sold 550 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2018, an estimated $24K.
AUA Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and held it in 5 quarters.
AUA Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $42K in Q1 2017.
75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2018.

Based on AUA Capital Management's 13F filing for Q1 2018, filed 15 May 2018.